Greg Roloff (@roloffgreg) 's Twitter Profile
Greg Roloff

@roloffgreg

Academic hematologist interested in leukemia, cellular therapy, hereditary🩸disorders. Buffalo born. Views, typos, and grammatical errors = mine

ID: 1268610580740550656

linkhttps://tinyurl.com/5xc5j7hs calendar_today04-06-2020 18:28:33

371 Tweet

603 Followers

750 Following

Wolf Blitzer (@wolfblitzer) 's Twitter Profile Photo

I’m in my office getting ready for “The Situation Room” tonight but I’m still so excited about our big ⁦Buffalo Bills⁩ win last night. #GoBills!

I’m in my office getting ready for “The Situation Room” tonight but I’m still so excited about our big ⁦<a href="/BuffaloBills/">Buffalo Bills</a>⁩ win last night. #GoBills!
Anand Patel (@anand_88_patel) 's Twitter Profile Photo

Thrilled to share a Haematologica review I wrote w/ the mentorship of Raajit Rampal, M.D.Ph.D.! We tackle MPN-AP/BP in a few ways including: -strategies to prevent progression -molecular data in allo-HCT decision-making -modification of MPN-AP/BP response criteria haematologica.org/article/view/h…

Thrilled to share a <a href="/Haematologica/">Haematologica</a> review I wrote w/ the mentorship of <a href="/RaajitRampal/">Raajit Rampal, M.D.Ph.D.</a>! We tackle MPN-AP/BP in a few ways including:
-strategies to prevent progression
-molecular data in allo-HCT decision-making
-modification of MPN-AP/BP response criteria

haematologica.org/article/view/h…
Haematologica (@haematologica) 's Twitter Profile Photo

How can we expedite the evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation for acute myeloid leukemia patients and chose the best donor? Read here the approach used by Roloff and colleagues. haematologica.org/article/view/h…

How can we expedite the evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation for acute myeloid leukemia patients and chose the best donor? Read here the approach used by Roloff and colleagues.
haematologica.org/article/view/h…
bshah (@bshah) 's Twitter Profile Photo

Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia | New England Journal of Medicine nejm.org/doi/full/10.10…

UChicago Pritzker School of Medicine (@uchipritzker) 's Twitter Profile Photo

For the seventh time, University of Chicago Medical Center has been named a Top Teaching Hospital by the The Leapfrog Group for its high standards for patient safety and quality care. Read more: pritzker.uchicago.edu/news/ucmc-leap…

For the seventh time, University of Chicago Medical Center has been named a Top Teaching Hospital by the <a href="/LeapfrogGroup/">The Leapfrog Group</a> for its high standards for patient safety and quality care. Read more: pritzker.uchicago.edu/news/ucmc-leap…
University of Chicago Hematology/Oncology (@uchicagohemonc) 's Twitter Profile Photo

Congratulations to our Section Chief, Dr. Soni Smith MD new electee to the ASCO Board of Directors as the Designated Medical Oncologist!! We see her dedicated & positive leadership daily & know how deserving she is of this honor! More from ASCO at brnw.ch/21wPuRZ

Susana A. Mendoza ☮️ (@susanamendoza10) 's Twitter Profile Photo

Excellent OpEd by Alderman Bill Conway Bill Conway 🇺🇸 on need to end the fiscal recklessness on full, daily display in Chicago by Mayor Brandon Johnson Brandon Johnson. Borrowing $830 million at a cost of more than $2 billion is insane. Read it & contact your alderman. chicagotribune.com/2025/02/14/opi…

UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

WATCH: Dan Olson discusses the potential of TIL therapy, a groundbreaking cancer treatment that transformed cancer patient Alla Pinzour's life. UChicago Medicine is proud to be the first in the Midwest to offer this innovative therapy. University of Chicago Hematology/Oncology ow.ly/pme750V2cHz

WATCH: <a href="/DanielOlsonMD/">Dan Olson</a> discusses the potential of TIL therapy, a groundbreaking cancer treatment that transformed cancer patient Alla Pinzour's life. <a href="/UChicagoMed/">UChicago Medicine</a> is proud to be the first in the Midwest to offer this innovative therapy. <a href="/UChicagoHemOnc/">University of Chicago Hematology/Oncology</a>
ow.ly/pme750V2cHz
University of Chicago Hematology/Oncology (@uchicagohemonc) 's Twitter Profile Photo

More great research coming from our University of Chicago Hem/Onc Fellows!! Drs. Shaw, Cannova, Johnston, and Madero-Marroquin in Blood Advances (doi.org/10.1182/blooda… and doi.org/10.1182/blooda…) & Dr. Cannova in Oncology Advance (clinical-lymphoma-myeloma-leukemia.com/article/S2152-…)!!

Greg Roloff (@roloffgreg) 's Twitter Profile Photo

Obecabtagene Autoleucel Emerges as an Avenue for Adults With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia ashpublications.org/thehematologis…

Mehdi Hamadani, MD (@medihumdani) 's Twitter Profile Photo

Our deeper dive on BMT CTN 1506 aka Morpho trial: FLT3-ITD/NPM1 co mutants with residual MRD uniquely benefit from #gilteratinib maintenance. FLT3-ITD/NPM1 co-mutation status may inform #alloHCT conditioning intensity decision #bmtsm #leusm ashpublications.org/bloodadvances/…